We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Select Bajaj Housing Finance Ltd from the dropdown. Choose how you wish to check the allotment (via Application Number, Demat Account, or PAN). Enter the relevant details and security CAPTCHA.
NEW DELHI: Bajaj Housing Finance Ltd's Rs 6, 560 crore initial public offer (IPO) was subscribed 63.60 times on Day 3. The issue received bids for 46,27,48,43,832 shares, against the 72,75,75,756 ...
MUMBAI: Bajaj Housing Finance Ltd has come out with first quarterly results post listing after separation from Bajaj Finance Ltd. After its bumper listing, the stock's performance has been muted.
MUMBAI: Bajaj Housing Finance Ltd (BHFL) stock hit a high of ₹181 per share after its blockbuster initial public offering in September. At its high, the share was trading at 9.6X price-to-book ...
Bajaj Finance also expanded into mortgage loans with another subsidiary Bajaj Housing Finance Limited. Another wholly-owned subsidiary Bajaj Financial Securities Limited commenced operations two ...
Bajaj Housing Finance's $782 mln IPO oversubscribed in busy week for Indian floats September 9, 2024 India's Bajaj Housing Finance targets $7 bln valuation in IPO September 3, 2024 India's Bajaj ...
Bajaj Housing Finance Limited was originally incorporated as Bajaj Financial Solutions Limited at Pune, Maharashtra as a Public Limited Company, pursuant to a Certificate of Incorporation dated ...
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
Private banks lift Indian shares to record closing highs June 20, 2024 India's Bajaj Housing Finance Ltd has filed with the country's markets regulator to raise up to 70 billion rupees ($838.11 ...
as the telehealth company announces a launch of a generic version of the GLP-1 weight-loss drug Ozempic set for 2025. Hims & Hers Health CFO Yemi Okupe spoke with Yahoo Finance earlier this week ...